Hyloris Pharmaceuticals
Boulevard de Patience et Beaujonc 3
4000 Liège
BE
Public Limited Company
Juridical SituationNormal situation
Established4/10/2017
Medium
Office administrative, office support and other business support activities
Management consultancy activities
Activities of holding companies
ESG Risk Cases
The Belgian regulator FSMA referred Hyloris to prosecutors over potential financial irregularities i…
TimelineFirst report on 2/5/2024 by De Tijd
Since then, updated 4 times
Last update on 28/8/2024
Hyloris Pharmaceuticals
SVR INVEST
In October 2024, the Belgian financial regulator FSMA warned pharmaceutical companies Biocartis and …
TimelineFirst report on 15/10/2024 by BELGA WIRE
Last update on 18/10/2024
Hyloris Pharmaceuticals
SVR INVEST
Sentiment Attention Over Time
- Total
- Neutral
- Positive
- Negative
The Sentiment Attention is produced by AI models developed by Sentometrics. Articles are connected to companies based on public information like company names, sectors, locations, linked companies, and company directors. Themes are assigned using keywords, and sentiment is analyzed with the help of AI prompts. A human team reviews and helps the system learn and improve over time.
Recent Relevant News
| Date | Sentiment | Theme | Headline | Source |
|---|---|---|---|---|
Date 20/11/2025 | Sentiment Positive | Theme Social Governance Financial health | Title Positive Update - Nov 20 | Source Source 1 |
Date 20/11/2025 | Sentiment Positive | Theme Financial health Governance | Title Positive Update - Nov 20 | Source Source 2 |
Date 19/11/2025 | Sentiment Positive | Theme Social Governance | Title Positive Update - Nov 19 | Source Source 3 |
Date 19/11/2025 | Sentiment Negative | Theme Governance | Title Negative Update - Nov 19 | Source Source 4 |
Date 17/11/2025 | Sentiment Positive | Theme Financial health | Title Positive Update - Nov 17 | Source Source 5 |
Unlock 25+ years of newsUnlock | ||||
Often Mentioned With
Company Network
Financials
As of 31/12/2024